{"id":"W2047013037","doi":"10.1017/s0317167100012105","title":"Monoclonal Antibodies and Progressive Multifocal Leukoencephalopathy","year":2011,"lang":"en","type":"review","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Canada","funders":"","keywords":"Progressive multifocal leukoencephalopathy; Natalizumab; Efalizumab; Medicine; Monoclonal antibody; Adalimumab; Rituximab; Adverse effect; Adverse Event Reporting System; Monoclonal; Pharmacovigilance; Infliximab; Internal medicine; Immunology; Antibody; Multiple sclerosis; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["sts"],"category_scores_codex":[0.002386614,0.0007421409,0.002100028,0.001722315,0.00252529,0.0006173867,0.001565903,0.0006216644,0.0002124422],"category_scores_gemma":[0.001938313,0.0004174753,0.0008172034,0.001222845,0.01471013,0.0007046046,0.0001320549,0.002584823,0.000007951969],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002389748,"about_ca_system_score_gemma":0.01069533,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006420219,"about_ca_topic_score_gemma":0.003662926,"domain_scores_codex":[0.9942254,0.001003602,0.001523752,0.0008331375,0.000747727,0.001666338],"domain_scores_gemma":[0.9931306,0.0005473601,0.001662229,0.0001954125,0.0004534122,0.00401096],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001900962,0.0001682182,0.1432749,0.0009577287,0.000251073,0.0780658,0.0004972802,0.00002778648,8.483032e-7,0.001051756,0.001166729,0.7743478],"study_design_scores_gemma":[0.0006870373,0.1004001,0.01645745,0.00529454,0.001945391,0.4267821,0.0001917686,0.0001614083,0.000003606035,0.004335239,0.4426032,0.001138213],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2156277,0.7817291,0.000001738622,0.0003279368,0.0007180792,0.0003239438,0.00003375611,0.00001880787,0.001218917],"genre_scores_gemma":[0.03052651,0.9665889,0.00143124,0.0008458164,0.00052176,0.000006791268,0.000001320486,0.0000298847,0.00004775549],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7732096,"threshold_uncertainty_score":0.9998277,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07475193843963476,"score_gpt":0.3321773307067408,"score_spread":0.257425392267106,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}